3rd Quarter - Report

IPOLICY SOLUTIONS for ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard HHS Request for Comment on the Update to the National Plan To Address Alzheimer's Disease RFI on Commonsense Policy Options to Lower Drug Prices for Patients Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP FDA clinical trial design requirements RFI on Health Coverage That Works for Everyone Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —
MARY LEE WATTS —

Contacted: Food & Drug Administration (FDA); SENATE

Medical/Disease Research/Clinical Labs MED

Regulation for Federal Financial Assistance

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —
MARY LEE WATTS —

Contacted: SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.